Corrigendum: Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS

Corrigendum: Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS

Saved in:

Bibliographic Details
Main Authors:	Paola Quaresima, Samuel H. Myers, Basilio Pintaudi, Rosario D’Anna, Michele Morelli, Vittorio Unfer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Endocrinology
Subjects:	gestational diabetes mellitus polycystic ovary syndrome insulin metformin myo-inositol
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1569086/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”
by: Cesare Aragona, et al.
Published: (2025-03-01)

Histochemical Effect of Capsaicin Alone or in Combination with The Metformin on Ovaries Structure After Induced a Polycystic Ovary Syndrome by Letrozole in Rats
by: Alia Mohammed Khudier, Karim H. Al-derawi, Labeed A. Al- saad
Published: (2024-03-01)

Effect of myo-inositol supplementation in mixed ovarian response IVF cohort: a systematic review and meta-analysis
by: Jianeng Zhang, et al.
Published: (2025-03-01)

Evaluation of therapeutic effects of Crocin in patients with polycystic ovary syndrome: A randomized Double-Blind clinical trial
by: Fatemeh Saghafi, et al.
Published: (2025-08-01)

Polycystic Ovary Syndrome (PCOS): Symptoms, Causes, and Treatment
by: Hai Bai, et al.
Published: (2024-05-01)

A Bibliometric Analysis of Global Research Trends in Polycystic Ovary Syndrome and Metformin
by: Bowen Tang, et al.
Published: (2024-03-01)

Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance
by: E. M. Bogatyreva, et al.
Published: (2018-07-01)

The impact of combined use of probiotics and metformin on metabolic parameters in patients with polycystic ovary syndrome
by: Xia Li, et al.
Published: (2025-12-01)

Metformin in polycystic ovary syndrome: unraveling multi-stage therapeutic mechanisms from puberty to long-term health outcomes
by: Weiwei Zeng, et al.
Published: (2025-08-01)

Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial
by: Haiyan Chen, et al.
Published: (2025-07-01)

Beyond phytic acid: Nutrigenetic and nutrigenomic insights into its hydrolysis, transport, and metabolism
by: Suyun Choi, et al.
Published: (2025-04-01)

Metformin prevents oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome via activation of Nrf2-HO-1 pathway
by: Jin-Jing Li, et al.
Published: (2025-12-01)

Dissociation of plasma oxyntomodulin levels from anthropometric measures and metabolic markers in women with polycystic ovary syndrome
by: Rachel C. Damasceno, et al.
Published: (2025-06-01)

Estimation of the hepcidin level and some Biochemical parameters in patients of polycystic ovary Syndrome in Kirkuk city
by: Sherin Bahgat Ayed AL- Tikriti, et al.
Published: (2019-08-01)

Distribution of polycystic ovary syndrome (PCOS) phenotypes in Iranian women: a cross-sectional study
by: Asma Kheirollahi, et al.
Published: (2025-05-01)

Anthropometrics of neonates born to mothers with PCOS with metformin or placebo exposure in utero
by: Guro Ørndal Nilsen, et al.
Published: (2024-01-01)

Study of the Relationship between the Sonographic Appearance of the Ovaries in Polycystic Ovary Syndrome and Different PCO Phenotypes
by: Farideh Marmazi, et al.
Published: (2025-07-01)

Optical resolution of racemic myo-inositol derivatives into enantiomers for the synthesis of inositol-containing phospholipids with natural structures
by: A. E. Stepanov, et al.
Published: (2011-04-01)

Placental and cerebral circulation in fetuses of mothers with polycystic ovary syndrome and the effect of Metformin exposure
by: Emma Nordtvedt, et al.
Published: (2025-07-01)

Knowledge about polycystic ovary syndrome (PCOS), body image, and depression by PCOS status among a sample of US females
by: Brianna M Magnusson, et al.
Published: (2025-09-01)

The Prevalence of Prenatal Diabetes Mellitus in Rania City: Women with Polycystic Ovaries
by: Renas Mohamed, et al.
Published: (2023-04-01)

Physical Activity vs. Pharmacotherapy in PCOS Treatment: A relief of Clinical Evidence on Exercise and Metformine Efficacy
by: Magdalena Bartold, et al.
Published: (2025-08-01)

Editorial: Internal and external factors affecting polycystic ovary syndrome
by: Alexandra E. Butler, et al.
Published: (2025-04-01)

Comparison of the Clinical Outcomes in Women with A or D PCOS Phenotypes versus Single Polycystic Ovary undergoing IVF-ET
by: Fangfang Dai, et al.
Published: (2024-02-01)

The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease
by: So-hyeon Hong, et al.
Published: (2025-08-01)

Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
by: Tsuyoshi Baba
Published: (2025-01-01)

Immunological aspects of polycystic ovary syndrome: A review
by: Yulia A. Kandrashlina, et al.
Published: (2025-01-01)

Modern aspects of management of patients with polycystic ovary syndrome
by: N. V. Avramenko, et al.
Published: (2020-12-01)

Violation of the Hormonal Spectrum in Polycystic Ovaries in Combination with Insulin Resistance. What is the Trigger: Insulin Resistance or Polycystic Ovary Disease?
by: Lomteva S V, et al.
Published: (2022-10-01)

Effectiveness, Tolerability and Safety of a Compound Based on D-chiro-inositol + Myo-inositol, Melatonin, Folic Acid, and Vitamin D in Patients with Menstrual Cycle Disorders
by: Silvia P. González, et al.
Published: (2024-02-01)

Body Fat Distribution in Thai Reproductive-Aged Polycystic Ovary Syndrome Women Compared with Non-Polycystic Ovary Syndrome Women
by: Thanyarat Wongwananuruk, et al.
Published: (2024-02-01)

Investigation of the prevalence of polycystic ovary syndrome in Hamedan province in 2021
by: Fatemeh Asadi, et al.
Published: (2025-03-01)

LAPAROSCOPY FOR THE RECOVERY OF REPRODUCTIVE HEALTH IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
by: I. N. Medvedevа, et al.
Published: (2018-02-01)

Estimation the activity of Copeptin, insulin, and C-peptide from patients with polycystic ovary syndrome
by: Entedhar R. Sarhat, et al.
Published: (2018-08-01)

Effect of myo-inositol on the prevention of gestational diabetes in high-risk pregnant women: An RCT
by: Ashraf Moini, et al.
Published: (2025-05-01)

The Effects of Limonin, Myo-Inositol, and L-Proline on the Cryopreservation of Debao Boar Semen
by: Qianhui Feng, et al.
Published: (2025-07-01)

Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome
by: Rui Hua, et al.
Published: (2025-08-01)

Effect and mechanism of resveratrol against polycystic ovary syndrome: a review
by: Hui Chang, et al.
Published: (2025-07-01)

Molecular Mechanisms of Endometrial Functioning in Women with Polycystic Ovary Syndrome
by: A. Yu. Sambyalova
Published: (2021-01-01)

Evaluation the levels of some hormones in women with polycystic ovary syndrome
by: Namareq Ata allah Mohemeed, et al.
Published: (2019-09-01)